DOH suspends AstraZeneca vaccine jabs on people aged below 60 | Inquirer News

DOH suspends AstraZeneca vaccine jabs on people aged below 60

/ 02:47 PM April 08, 2021

The spread of coronavirus disease (COVID-19) in Dublin

A vial of AstraZeneca COVID-19 vaccine is seen at the Aviva Stadium mass vaccination centre, amid the coronavirus disease (COVID-19) pandemic, in Dublin, Ireland, April 4, 2021. REUTERS/Clodagh Kilcoyne

MANILA, Philippines — The Department of Health (DOH) adopted on Thursday the recommendation of the Food and Drug Administration (FDA) to temporarily suspend the use of AstraZeneca’s COVID-19 vaccine for individuals aged below 60, following reports on “rare cases” of blood clots with low platelets in some individuals who have received the vaccine.

“We are aware of the recommendation of the European Medicines Agency (EMA) to list blood clots as very rare side effects of the AstraZeneca vaccine,” FDA Director General Eric Domingo said in a statement issued by DOH.

ADVERTISEMENT

He said that while the country has not seen such incidents, the FDA has recommended to temporarily suspend the use of the vaccine for those below 60 years old as authorities await results of the review being done by local experts and the guidance of the World Health Organization.

FEATURED STORIES

“I want to emphasize that this temporary suspension DOES NOT MEAN that the vaccine is unsafe or ineffective—it just means that we are taking precautionary measures to ensure the safety of every Filipino,” he added.

Domingo also noted that the rare side effect was so far observed only after the administration of the first dose.

“So if nothing happened after the first dose then no problem sa (on the) second dose. This is very rare but it will be included in the things to watch out for, so we have to review the data and prepare before the next batch of vaccines come,” he said.

He assured that the review for the AstraZeneca vaccine will be completed before the scheduled administration of the second shots.

Earlier in the day, Domingo said the FDA has recommended to temporarily suspend the administration of AstraZeneca COVID-19 vaccines on people below 60 years old after a link between the vaccine and so-called very rare blood clot events in the brain (cerebral venous sinus thrombosis or CVST) has been found by a European study.

However, Domingo said the government maintains that the benefits of vaccination continue to outweigh the risks and urged everyone to get vaccinated when it’s their turn.

ADVERTISEMENT

The National Task Force against COVID-19 and the DOH also reiterated that vaccination is safe and free, and urged senior citizens and persons with comorbidities to receive the available vaccines from their local government units to acquire the protection it provides.

EDV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: AstraZeneca, coronavirus Philippines, COVID-19, COVID-19 Vaccine

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.